英文名称:Ascentage Pharma Group Corp Limited 公司现状:仍註冊 公司类别:私人股份有限公司 成立日期:2009-05-22 注册编号:1340292(点击查看企业详情) 历史名称:2019年10月9日 Ascentage Pharma Group Corp Limited 亞盛醫藥集團(香港)有限公司 2017年12月27日 Ascentage Pharma Group Corp Limited 亞盛醫藥集團有限公...
Ascentage Pharma Group Corp Limited was formed on 2009-05-22 in Hong Kong. It is currently active. FORMATION DETAILS Registration Number:1340292 Type:Local Company - Private Status:Active Date of Formation:2009-05-22 Name History:Ascentage Pharma Group Corp Limited ...
Ascentage Pharma Group Corp. Ltd. said two of its novel candidates have been included in the 2025 Chinese Society of Clinical Oncology Guidelines, including its in-house developed Bcl-2 selective inhibitor, lisaftoclax (APG-2575), which is under review in China and could be the first domestica...
Rockville, MD 20850 +1 (301) 291-5658 Name Patient Program-HQP1351 - NPP-olverembatinib@ascentage.com Grants and Giving - grants@ascentage.com Clinical Trials - clinical-trials@ascentage.com Privacy Policy ©2022 Ascentage Pharma (Suzhou) Co., Ltd. and Ascentage Pharma Group Corp Ltd....
and Director at Ascentage Pharma Group Corp. Ltd. Former jobs include Vice President-Biology at S*BIO Pte Ltd. from 2002 to 2003, Member-Supervisory Board & Professor at Sun Yat-Sen University from 2003 to 2006, and President at The Chinese Biopharmaceutical Association from 2005 to 2006. Edu...
ASCENTAGE PHARMA GROUP CORP LIMITED (Hong Kong, CN) International Classes: A61K31/496;A61K31/437;A61K31/453;A61K31/519;A61K45/06;A61P35/04 View Patent Images: Download PDF 20210275522 Primary Examiner: PIHONAK, SARAH Attorney, Agent or Firm: ...